🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Autistic Symptomatology and Sensory Profile in Children With Prader-Willi Syndrome

Recruitingn/aAges 3 Years - 16 YearsAllUniversity Hospital, Toulouse
NCT06877715 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Prader-Willi Syndrome (PWS) is a rare neurodevelopmental disorder stemming from genetic damage in the 15q11-q13 region, leading to hypothalamic dysfunction. Individuals with PWS often exhibit social interaction challenges, intellectual deficits, significant eating disorders, mood disturbances, and sensory-related autistic features. Although PWS is recognized by DSM-5 as a genetic cause of Autism Spectrum Disorder (ASD), ASD diagnosis in PWS remains rare in France. The CASSPER study aims to investigate the distinct autistic and sensory profiles in children with PWS, also analyzing the potential impact of early oxytocin treatment on these manifestations, in line with recommendations for early and tailored intervention.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Child with genetically confirmed PWS and identification of genetic subtype; * Child aged between 3 and 16 years; * Hospitalisation or multidisciplinary consultation planned for the child's routine follow-up at one of the investigating centres; * No parental/legal guardian objection. Exclusion Criteria: * Change in psychotropic treatment (start, change in dose or discontinuation) in the past 3 months; * Inability to provide clear information to parents/legal guardian; * Not covered by social security.
💊

What it tests

  • psychological and sensorial tests
📍

Where

1 site
Children Hospital
Toulouse, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy